These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34544545)

  • 1. Development of a Sandwich Chemiluminescence Immunoassay for the Detection of Intact Procollagen Type I N Propeptide with Magnetic Nanosphere Carrier Technology.
    Song L; Xie C; Liu X; Huo Z; Xie Y; Gao J; Zhou S; Shen J; Tang X; Liu X
    J Biomed Nanotechnol; 2021 Aug; 17(8):1690-1698. PubMed ID: 34544545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development and evaluation of a chemiluminescence immunoassay for type Ⅰ procollagen N-terminal peptide].
    Ren H; Han S; Chen X; Li S; Bai Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Dec; 37(12):4406-4414. PubMed ID: 34984885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing bone formation in patients with chronic kidney disease using procollagen type I N-terminal propeptide (PINP): The choice of assay makes a difference.
    Tridimas A; Milan A; Marks E
    Ann Clin Biochem; 2021 Sep; 58(5):528-536. PubMed ID: 34096326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.
    Cavalier E; Eastell R; Rye Jørgensen N; Makris K; Tournis S; Vasikaran S; Kanis JA; Cooper C; Pottel H; Morris HA;
    Clin Chem Lab Med; 2019 Sep; 57(10):1546-1555. PubMed ID: 31085740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
    Koivula MK; Risteli L; Risteli J
    Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative lateral flow immunoassay for rapid detection of procollagen type I N-terminal propeptide in the monitoring of osteoporosis treatment.
    Chen CA; Chiu PY; Huang TH; Ho NY; Kao FC; Tsai TT
    Anal Chim Acta; 2023 Jan; 1239():340695. PubMed ID: 36628763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.
    Marin L; Koivula MK; Jukkola-Vuorinen A; Leino A; Risteli J
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):447-51. PubMed ID: 21733929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
    Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children.
    Morovat A; Catchpole A; Meurisse A; Carlisi A; Bekaert AC; Rousselle O; Paddon M; James T; Cavalier E
    Clin Chem Lab Med; 2013 Oct; 51(10):2009-18. PubMed ID: 24072575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age- and sex-specific concentrations of bone remodeling markers in healthy Indian adults with and without vitamin D deficiency.
    Pal R; Aggarwal A; Sachdeva N; Ram S; Garg A; Bhansali A; Bhadada SK
    Arch Osteoporos; 2021 Jan; 16(1):10. PubMed ID: 33415509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.
    Tähtelä R; Turpeinen M; Sorva R; Karonen SL
    Clin Biochem; 1997 Feb; 30(1):35-40. PubMed ID: 9056107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism.
    Orum O; Hansen M; Jensen CH; Sørensen HA; Jensen LB; Hørslev-Petersen K; Teisner B
    Bone; 1996 Aug; 19(2):157-63. PubMed ID: 8853860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.
    Yamamoto T; Tsujimoto M; Sowa H
    Clin Interv Aging; 2015; 10():1101-9. PubMed ID: 26185429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of commercial assays for PINP; the way forward.
    Vasikaran SD; Bhattoa HP; Eastell R; Heijboer AC; Jørgensen NR; Makris K; Ulmer C; Kanis JA; Cooper C; Silverman S; Cavalier E
    Osteoporos Int; 2020 Mar; 31(3):409-412. PubMed ID: 31975180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density.
    Scariano JK; Garry PJ; Montoya GD; Duran-Valdez E; Baumgartner RN
    Scand J Clin Lab Invest; 2002; 62(3):237-43. PubMed ID: 12088343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases.
    Gudowska-Sawczuk M; Wrona A; Gruszewska E; Cylwik B; Panasiuk A; Flisiak R; Chrostek L
    Scand J Clin Lab Invest; 2018; 78(1-2):125-130. PubMed ID: 29272979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-label time-resolved fluorescence immunoassay for screening of osteoporosis based on simultaneous detection of C-terminal telopeptide (β-CTX) and aminoterminal propeptide (P1NP) of type I procollagen.
    Xu Y; Wang Q; Hou G; Yao H; Zhao H
    Scand J Clin Lab Invest; 2019; 79(1-2):80-85. PubMed ID: 30638079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.